Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 243

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1B
Chunk 243
---
 31, 2027 (ii) upon a merger or acquisition of the Company, provided the holder
agrees to accept the underlying shares in writing, or (iii) upon the holders last date of employment, provided the holder agrees to accept
the underlying shares in writing.

(3)Market value is calculated based on the closing price of our common stock of $0.70 per share on December
31, 2024, times the number of shares subject to the RSU award. Each RSU represents the contingent right to receive, upon vesting, one
share of our common stock.

 43 

    ITEM 12.
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Share Ownership

The following table sets forth information, as of
March 31, 2025, regarding the beneficial ownership of our common stock and Series B Preferred by:

·Each person known by us to be a beneficial owner
of more than five percent (5%) of our outstanding common stock; 

·each person known by us to be a beneficial owner
of more than five percent (5%) of our Series B Preferred Stock; 

·each of our directors;

·each of our named executive officers; and 

·all current directors and named executive officers
as a group.

The amounts and percentage of common stock and Series
B Preferred beneficially owned are reported on the basis of regulations of the Securities and Exchange Commission (“SEC”)
governing the determination of beneficial ownership of securities. Under the rules of the SEC, a person is deemed to be a “beneficial
owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the
voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such
security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership
within 60 days of March 31, 2025, including, but not limited to, any right to acquire the security upon vesting of a restricted stock
units (“RSUs”) or through the exercise of any option or warrant or through the conversion of a security. Any securities not
outstanding that are subject to outstanding RSUs, options, warrants or other convertible securities shall be deemed to be outstanding
for the purpose of computing the percentage of outstanding securities of the class owned